Literature DB >> 11993686

Neuroectodermal and neuroendocrine tumors principally seen in children.

D M Parham1.   

Abstract

Neuroectodermal tumors comprise a large proportion of childhood neoplasms. Neuroblastic tumors, including neuroblastoma, ganglioneuroblastoma, and ganglioneuroma, are the most frequent extracranial solid cancers of childhood, occurring primarily in infants and toddlers. Primitive neuroectodermal tumors, including Ewing sarcoma and peripheral neuroepitheliomas, occur most frequently in older children and adolescents, and as pediatric sarcomas are second in frequency only to rhabdomyosarcomas. Rarer neuroectodermal tumors include desmoplastic small cell tumors, esthesioneuroblastomas, and melanotic neuroectodermal tumors, the first two entities occurring as rather site-specific lesions in the abdomen and nose, respectively. Diagnosis can be difficult due to the undifferentiated nature of many of these cancers, but ancillary studies, including electron microscopy, immunohistochemistry, cytogenetics, and molecular genetics, enhance their recognition. The molecular nature of childhood neuroectodermal tumors is as diverse as their histology, ranging from the fusion genes characterizing the Ewing sarcoma family of tumors to the proto-oncogene amplification seen in aggressive neuroblastomas.

Entities:  

Mesh:

Year:  2001        PMID: 11993686     DOI: 10.1309/2A98-GPDN-EN87-5J0L

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Clinical, ultrasonographic, and laboratory findings in 12 llamas and 12 alpacas with malignant round cell tumors.

Authors:  Jeanne M Martin; Beth A Valentine; Christopher K Cebra
Journal:  Can Vet J       Date:  2010-12       Impact factor: 1.008

2.  Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.

Authors:  Pournima Navalkele; M Sue O'Dorisio; Thomas M O'Dorisio; Gideon K D Zamba; Charles F Lynch
Journal:  Pediatr Blood Cancer       Date:  2011-01       Impact factor: 3.167

3.  Peripheral primitive neuroectodermal tumors arising in the pancreas: the first case report in Asia and a review of the 14 total reported cases in the world.

Authors:  Yilei Mao; Xinting Sang; Naixin Liang; Huayu Yang; Xin Lu; Zhiying Yang; Shunda Du; Yiyao Xu; Haitao Zhao; Shouxian Zhong; Jiefu Huang; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2013-02       Impact factor: 7.293

4.  Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition.

Authors:  Yoav D Shaul; Elizaveta Freinkman; William C Comb; Jason R Cantor; Wai Leong Tam; Prathapan Thiru; Dohoon Kim; Naama Kanarek; Michael E Pacold; Walter W Chen; Brian Bierie; Richard Possemato; Ferenc Reinhardt; Robert A Weinberg; Michael B Yaffe; David M Sabatini
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

5.  Can Archival Tissue Reveal Answers to Modern Research Questions?: Computer-Aided Histological Assessment of Neuroblastoma Tumours Collected over 60 Years.

Authors:  Albert Chetcuti; Nicole Mackie; Siamak Tafavogh; Nicole Graf; Tony Henwood; Amanda Charlton; Daniel Catchpoole
Journal:  Microarrays (Basel)       Date:  2014-02-28

6.  Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.

Authors:  Cristiane S Ferreira-Facio; Cristiane Milito; Vitor Botafogo; Marcela Fontana; Leandro S Thiago; Elen Oliveira; Ariovaldo S da Rocha-Filho; Fernando Werneck; Danielle N Forny; Samuel Dekermacher; Ana Paula de Azambuja; Sima Esther Ferman; Paulo Antônio Silvestre de Faria; Marcelo G P Land; Alberto Orfao; Elaine S Costa
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

7.  Silencing of the integrin-linked kinase gene suppresses the proliferation, migration and invasion of pancreatic cancer cells (Panc-1).

Authors:  Xiang-Yu Zhu; Ning Liu; Wei Liu; Shao-Wei Song; Ke-Jian Guo
Journal:  Genet Mol Biol       Date:  2012-05-17       Impact factor: 1.771

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.